Clinical Trials Logo

Filter by:
NCT ID: NCT03648645 Active, not recruiting - Clinical trials for Hypertension in Pregnancy

Hypertensive Pregnant Women Monitored by Teletransmitted Self-measurements of Blood Pressure

FETH
Start date: May 25, 2022
Phase: N/A
Study type: Interventional

The occurrence of arterial hypertension (AH) during pregnancy is a major cause of fetal, neonatal and maternal morbidity and mortality in western countries. It is estimated that about 10% of pregnancies are complicated by AH (80 000 women / year in France). It is therefore essential to diagnose AH with certainty in order to set-up appropriate care and follow its evolution.

NCT ID: NCT03643224 Active, not recruiting - Atrial Fibrillation Clinical Trials

DiamondTemp™ System for the Treatment of Persistent Atrial Fibrillation

Diamond-AFII
Start date: September 20, 2018
Phase: N/A
Study type: Interventional

The purpose of the Diamond-AF II study is to establish the safety and effectiveness of the DiamondTemp Ablation System for the treatment of drug refractory, symptomatic persistent atrial fibrillation in patients.

NCT ID: NCT03643133 Active, not recruiting - Osteosarcoma Clinical Trials

Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

SARCOME13
Start date: October 23, 2018
Phase: Phase 2
Study type: Interventional

Trial evaluating the impact on efficacy of mifamurtide as add-on treatment to post-operative chemotherapy compared to post-operative chemotherapy alone in first-line treatment of patients with high-risk osteosarcoma (defined as metastatic osteosarcoma at diagnosis or localised osteosarcoma with poor histological response).

NCT ID: NCT03642808 Active, not recruiting - Clinical trials for Osteoporotic Fractures

Optimisation of Falls Prevention After Low-energy Osteoporotic Fractures: Feasibility Study

OPTICHUTE
Start date: July 27, 2018
Phase: N/A
Study type: Interventional

Within the Groupe Hospitalier Paris Saint-Joseph (GHPSJ), a reinforced medical care of osteoporosis ('Fracture Liaison service') was organized for osteoporotic fractured patients. The evaluation of benefits of this program through a randomized study showed an improvement in diagnostic tests performed (bone densitometry) and antiosteoporotic treatment initiated (OPTIPOST study, being published in BMJ). However, of 323 patients included, 91 presented a new fracture within 12 months. Among them, 40/126 patients (31.7%) were in the reinforced medical care arm. This result clearly demonstrates the need for a specific medical care program for patients with osteoporotic fracture falling regularly.

NCT ID: NCT03642782 Active, not recruiting - Glaucoma Clinical Trials

Evaluation of the Electroretinogram Pattern (Diopsys® NOVA System) for the Early Diagnosis of Glaucoma

DIOPSYS
Start date: July 3, 2018
Phase: N/A
Study type: Interventional

Glaucoma is a common and potentially blinding disease. It is characterized by an optic nerve damage, a visual field defect and elevated intraocular pressure (IOP). The loss of retinal nerve fibers is accompanied by functional impairment in the territories corresponding to deficits of the visual field. However, this structure-function relationship is not always found initially. These discrepancies are mainly chronological: the structural damage preceding the functional impairment sometimes of several years

NCT ID: NCT03640455 Active, not recruiting - Dyspnea Clinical Trials

Randomized Study Evaluating the Efficacy of Low Intensity Transcranial Electrical Stimulation (Tdcs) for the Relief of Dyspnea

tDCS-DYSP-REA
Start date: November 9, 2018
Phase: Phase 2
Study type: Interventional

Nearly half (47%) of patients with mechanical ventilation in the intensive care unit report having dyspnea. This respiratory distress, with a feeling of "thirst for air", often reaches unbearable limits and is a major factor in the deterioration of the quality of life and the prognosis of patients. Physiopathological mechanisms of dyspnea are beginning better understood and have analogies with those of pain. Like pain, dyspnea often persists despite appropriate treatment of the cause, because of perceptual dysfunction related to changes in cortical excitability and neuronal plasticity and requires specific treatments. Studies have shown that Transcranial Stimulation by low Current (tDCS) was able to modulate the perception of acute pain induced and chronic pain. The tDCS modulates the functioning of a whole set of brain structures including the anterior cingulate gyrus, the prefrontal cortex, the thalamus and the brain stem, some of which have an established role in the central integration of pain and dyspnea. The investigators have recently demonstrated that the application of tDCS on the primary cortical motor area reduces the excitability of the central neurological pathways dedicated to the respiratory muscles in healthy subjects. The investigators therefore hypothesize that tDCS could relieve dyspnea in intensive care. In this research project, the investigators propose to evaluate the efficiency of tDCS on dyspnea in patients admitted to intensive care unit, having sepsis and mechanically ventilated.

NCT ID: NCT03639051 Active, not recruiting - COPD Clinical Trials

Evaluation of the Safety and Efficacy of TLD in Patients With COPD

AIRFLOW-3
Start date: May 23, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.

NCT ID: NCT03638674 Active, not recruiting - Bone Fracture Clinical Trials

Evaluation of Agreement Between CT Scan and 3D-DXA Measurements on the Lombar Spine

3D DXA SPINE
Start date: February 26, 2019
Phase: N/A
Study type: Interventional

Dual-energy X-ray Absorptiometry is frequently used to measure bone mineral density. A new medical device, Box 3D DXA, creates a 3D image using a statistics reconstruction model developed on the femur. This new imaging technique does not require additional irradiation and ought to improve bone measures as well as incorporating densitometric parameters into the diagnosis. This study will test the reconstruction of the 3D image from lombar spine measurements and compare accuracy against measurements made using CT scan.

NCT ID: NCT03637738 Active, not recruiting - Menopausal Patients Clinical Trials

Medico Economic Study, Comparing Intrabeam® on Surgical Resection Bed to Conventional Surgery + EBRT, in Breast Cancer

RIOP-SEIN
Start date: June 2012
Phase: N/A
Study type: Interventional

Current breast cancer treatment is based on surgery, radiation, chemotherapy and hormonotherapy. Conservative surgery or mastectomy are followed by complementary externe radiotherapy. This adjuvant external breast radiotherapy (EBRT) is heavy, spread over more than 6 weeks with : - 25 sessions and delivery of a unit dose of 2 Gy to obtain a total dose of 50 Gy (5 sessions per week in general); - 16 Gy overimpression (boost) dose located in the tumour bed, in 5 to 8 fractions, in situations at high risk of recurrence. In addition, EBRT is responsible for many adverse effects, some of which can lead to lasting or permanent sequelae. Many focused partial breast irradiation techniques have been developed in recent years with the objective of reducing the duration and morbidity of overall breast irradiation. Among these techniques, intraoperative breast radiotherapy (IBRT) is recommended in cancers diagnosed at early stages for which tumorectomy is expected and which present a low risk of recurrence. The main advantages of IBRTare : - Improvement of the quality of life due to a single session of radiotherapy associated with surgical ; - Increased precision to deliver the necessary dose in tumour tissue; - Preservation of surrounding healthy tissue ; - Reduction in the overall cost of treatment through shorter hospital stays and the absence of medical transport for conventional radiotherapy sessions. RIOP SEIN is a project supported by Institut National du Cancer (INCa) , which consists of a medico-economic evaluation of IBRT, with Intrabeam® system on surgical resection bed relative to conventional surgery + EBRT in postmenopausal patients operated by conservative surgery for Low risk breast cancer

NCT ID: NCT03636438 Active, not recruiting - Clinical trials for Ornithine Transcarbamylase (OTC) Deficiency

Long Term Follow Up to Evaluate DTX301 in Adults With Late-Onset OTC Deficiency

CAPtivate
Start date: August 30, 2018
Phase:
Study type: Observational

Determine the long-term safety of DTX301 following a single intravenous (IV) dose in adults with late-onset ornithine transcarbamylase (OTC) deficiency.